Here's the live share price of Orchid Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Orchid Pharma | 5.02 | 17.90 | 84.42 | 39.07 | 40.04 | 26.08 | 10.56 |
| Sun Pharmaceutical Industries | 1.29 | 7.52 | 16.78 | 11.08 | 15.35 | 21.61 | 23.58 |
| Divi's Laboratories | 1.56 | 3.23 | 13.08 | 5.82 | 0.48 | 23.56 | 8.40 |
| Torrent Pharmaceuticals | 3.80 | 8.24 | 18.37 | 25.29 | 49.30 | 36.55 | 26.83 |
| Cipla | -2.12 | 3.22 | 17.85 | -2.63 | -3.87 | 11.60 | 8.28 |
| Zydus Lifesciences | -0.58 | 2.60 | 22.89 | 26.75 | 15.80 | 24.67 | 11.92 |
| Lupin | 0.71 | 9.66 | 7.84 | 13.88 | 31.75 | 39.79 | 16.70 |
| Mankind Pharma | -0.56 | 6.12 | 21.04 | 13.02 | -2.37 | 13.26 | 12.06 |
| Dr. Reddy's Laboratories | -10.55 | -3.57 | -0.46 | 1.14 | -1.95 | 5.98 | 2.29 |
| Aurobindo Pharma | -4.21 | 6.00 | 15.84 | 32.34 | 38.01 | 28.23 | 10.54 |
| Laurus Labs | 1.17 | 12.18 | 43.37 | 49.65 | 97.18 | 63.59 | 18.17 |
| Alkem Laboratories | -0.20 | 4.87 | 3.74 | -5.26 | 15.66 | 16.56 | 10.62 |
| Biocon | -5.09 | -2.94 | 17.28 | 8.74 | 8.28 | 16.85 | 0.87 |
| Glenmark Pharmaceuticals | 4.28 | 7.47 | 5.03 | 14.18 | 5.63 | 50.90 | 28.57 |
| Abbott India | 5.85 | 4.95 | 6.37 | -3.70 | -20.48 | 4.95 | 9.62 |
| Ipca Laboratories | 2.92 | 13.63 | 26.34 | 19.93 | 26.47 | 33.78 | 11.62 |
| Ajanta Pharma | 2.55 | 8.62 | 17.78 | 24.75 | 29.78 | 34.57 | 18.86 |
| Anthem Biosciences | -2.56 | -3.83 | 2.77 | 21.44 | 2.69 | 0.89 | 0.53 |
| GlaxoSmithKline Pharmaceuticals | 1.06 | 15.00 | 0.34 | 0.81 | -25.42 | 20.29 | 10.07 |
| Gland Pharma | 0.29 | 7.03 | 43.32 | 44.88 | 32.73 | 30.66 | -7.29 |
Source: Dion Global
Over the last one year, Orchid Pharma has gained 40.04% compared to peers like Sun Pharmaceutical Industries (15.35%), Divi's Laboratories (0.48%), Torrent Pharmaceuticals (49.30%). From a 5 year perspective, Orchid Pharma has underperformed peers relative to Sun Pharmaceutical Industries (23.58%) and Divi's Laboratories (8.40%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 973.36 | 997.97 |
| 10 | 970.7 | 983.4 |
| 20 | 972.26 | 954.86 |
| 50 | 827.33 | 858.24 |
| 100 | 699.07 | 783.57 |
| 200 | 731.96 | 769.46 |
Source: Dion Global
In the latest quarter, Orchid Pharma remained same as its previous close in promoter holding, while DII stake increased to 20.24%, FII holding fell to 0.87%, and public shareholding moved down to 9.04% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 13,68,070 | 1.17 | 108.42 | |
| 9,90,763 | 0.4 | 78.52 | |
| 4,55,183 | 0.31 | 36.07 | |
| 4,43,891 | 0.13 | 35.18 | |
| 2,83,362 | 0.45 | 22.46 | |
| 2,64,308 | 0.08 | 20.95 | |
| 1,50,000 | 0.41 | 11.89 | |
| 1,40,765 | 0.71 | 11.16 | |
| 1,01,402 | 0.66 | 8.04 | |
| 64,654 | 0.31 | 5.12 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jul 11, 2026, 10:25 PM IST IST | Orchid Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jul 11, 2026, 02:06 AM IST IST | Orchid Pharma - Corporate Action For Fixation Of Record Date |
| Jul 11, 2026, 01:51 AM IST IST | Orchid Pharma - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association |
| Jul 11, 2026, 01:10 AM IST IST | Orchid Pharma - Board Meeting Outcome for Intimation Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Require |
| Jul 11, 2026, 01:03 AM IST IST | Orchid Pharma - Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited ('Amalgamating Company') With Or |
Source: Dion Global
Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 811.33 Cr. and Equity Capital is Rs. 50.72 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Orchid Pharma is ₹1,005.00 as on Jul 13, 2026.
The Orchid Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Orchid Pharma is ₹5,109.44 Cr as on Jul 13, 2026.
Today’s highest and lowest price of Orchid Pharma are ₹1,034.25 and ₹994.50.
The 52-week high/low is the highest and lowest price at which Orchid Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Orchid Pharma is ₹1,096.40 and 52-week low of Orchid Pharma is ₹471.30 as on Jul 13, 2026.
The Orchid Pharma has shown returns of -0.28% over the past day, 17.9% for the past month, 84.42% over 3 months, 40.04% over 1 year, 26.08% across 3 years, and 10.56% over 5 years.
P/E ratio of and PB ratio of Orchid Pharma are 251.03 and 3.97 on Jul 13, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global